WhiteLab Genomics
Unleashing the potential of DNA and RNA based therapies using AI
Paris, France · Founded 2019 · $10.0M raised
- Headquarters
- Paris
- Employees
- 11–50
- Founded
- 2019
- Website
- whitelabgx.com
- Total Funding
- $10.0M
- Last Round
- $10.0M Series ASep 2022
- Rounds
- 1
About
We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.
Summary
WhiteLab Genomics is an Artificial Intelligence company based in Paris, France, founded in 2019. It has raised $10.0M in total across 1 round, most recently a $10.0M Series A round in Sep 2022. Investors include Omnes Capital, Debiopharm Innovation and Alven.
Tech & App Stack
9 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2022
Investors
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...